ARCHIVES

Volasertib and LDAC Doubled Response in Older Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Schilsky Named ASCO Chief Medical Officer

November 1, 2012

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

American Cancer Society Publishes CT Screening Guidelines for Lung Cancer

January 11, 2013

Kimes, Lenfant, To Retire

July 11, 2003

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008